[HTML][HTML]Transcatheter aortic-valve replacement with a balloon-expandable valve in low-risk patients
…,RT哈恩, P Blanke, MRWilliams…… England Journal of …, 2019 - Mass Medical Soc
Background Among patients with aortic stenosis who are at intermediate or high risk for
death with surgery, major outcomes are similar with transcatheter aortic-valve replacement (…
death with surgery, major outcomes are similar with transcatheter aortic-valve replacement (…
Expression of VEGFR-2 and AC133 by circulating human CD34+cells identifies a population of functional endothelial precursors
…, D Pereira, Z Zhu,WJ Lane, MWilliams…Blood, The Journal …, 2000 - ashpublications.org
Emerging data suggest that a subset of circulating human CD34 + cells have phenotypic
features of endothelial cells. Whether these cells are sloughed mature endothelial cells or …
features of endothelial cells. Whether these cells are sloughed mature endothelial cells or …
[HTML][HTML]Transcatheter or surgical aortic-valve replacement in intermediate-risk patients
…, V Babaliaros,WY Szeto, MRWilliams…… England Journal of …, 2016 - Mass Medical Soc
Background Previous trials have shown that among high-risk patients with aortic stenosis,
survival rates are similar with transcatheter aortic-valve replacement (TAVR) and surgical …
survival rates are similar with transcatheter aortic-valve replacement (TAVR) and surgical …
[HTML][HTML]Transcatheter versus surgical aortic-valve replacement in high-risk patients
…, GP Fontana,RR Makkar, MWilliams…… England Journal of …, 2011 - Mass Medical Soc
Background The use of transcatheter aortic-valve replacement has been shown to reduce
mortality among high-risk patients with aortic stenosis who are not candidates for surgical …
mortality among high-risk patients with aortic stenosis who are not candidates for surgical …
[HTML][HTML]Two-year outcomes after transcatheter or surgical aortic-valve replacement
SK Kodali, MRWilliams, CR Smith… - … England Journal of …, 2012 - Mass Medical Soc
Background The Placement of Aortic Transcatheter Valves (PARTNER) trial showed that
among high-risk patients with aortic stenosis, the 1-year survival rates are similar with …
among high-risk patients with aortic stenosis, the 1-year survival rates are similar with …
[HTML][HTML]Surgical or transcatheter aortic-valve replacement in intermediate-risk patients
…, JK Oh, PS Olsen, N Piazza, MWilliams…New England journal …, 2017 - Mass Medical Soc
Background Although transcatheter aortic-valve replacement (TAVR) is an accepted alternative
to surgery in patients with severe aortic stenosis who are at high surgical risk, less is …
to surgery in patients with severe aortic stenosis who are at high surgical risk, less is …
5-year outcomes of transcatheter aortic valve replacement or surgical aortic valve replacement for high surgical risk patients with aortic stenosis (PARTNER 1): a …
…, A Pichard,HC Herrmann, DL Brown, MWilliams…The Lancet, 2015 - Elsevier
Background The Placement of Aortic Transcatheter Valves (PARTNER) trial showed that
mortality at 1 year, 2 years, and 3 years is much the same with transcatheter aortic valve …
mortality at 1 year, 2 years, and 3 years is much the same with transcatheter aortic valve …
[HTML][HTML]Five-year outcomes of transcatheter or surgical aortic-valve replacement
…, TM Dewey, V Babaliaros, MRWilliams…… England Journal of …, 2020 - Mass Medical Soc
Background There are scant data on long-term clinical outcomes and bioprosthetic-valve
function after transcatheter aortic-valve replacement (TAVR) as compared with surgical aortic-…
function after transcatheter aortic-valve replacement (TAVR) as compared with surgical aortic-…
Transcatheter aortic valve replacement versus surgical valve replacement in intermediate-risk patients: a propensity score analysis
…, S Kodali,RR Makkar,HC Herrmann, MWilliams…The Lancet, 2016 - Elsevier
Background Transcatheter aortic valve replacement (TAVR) with the SAPIEN 3 valve
demonstrates good 30 day clinical outcomes in patients with severe aortic stenosis who are at …
demonstrates good 30 day clinical outcomes in patients with severe aortic stenosis who are at …
5-year outcomes of transcatheter aortic valve replacement compared with standard treatment for patients with inoperable aortic stenosis (PARTNER 1): a randomised …
…,HC Herrmann,WY Szeto, AD Pichard, MRWilliams…The Lancet, 2015 - Elsevier
Background Based on the early results of the Placement of Aortic Transcatheter Valves (PARTNER)
trial, transcatheter aortic valve replacement (TAVR) is an accepted treatment for …
trial, transcatheter aortic valve replacement (TAVR) is an accepted treatment for …